Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat (original) (raw)

Abstract

The objective of the present study was to determine the sites of action of the cytokine, interleukin-1 (IL-1), in the febrile response to local in¯ammation in the rat, by comparing the importance of IL-1 in the local tissues, the circulation and the brain. This was achieved by injecting lipopolysaccharide (LPS, 100 mg kg 71) into a subcutaneous air pouch and testing the eects of blocking IL-1 action with the human recombinant interleukin-1 receptor antagonist (IL-1ra) injected either into the air pouch, intraperitoneally (1 mg kg 71 , 0+1 h, i.p.), or intracerebroventricularly (200 mg/rat, 0+1 h, i.c.v.). 2 To investigate the eect of IL-1ra on fever and the induction of local and circulating cytokines (IL-1 and IL-6), separate experiments were performed in which groups of animals were killed 1.5, 3 or 5 h after LPS injection. Plasma and pouch¯uid samples were collected for bioassay of IL-1 and IL-6. 3 Injection of LPS into the air pouch signi®cantly increased (1.58C) body temperature, local (air pouch) concentrations of bioactive IL-1 and IL-6, and circulating bioactive IL-6, compared to saline-treated controls. 4 Injection of IL-1ra into the pouch signi®cantly attenuated LPS fever (P50.001). This decrease in body temperature was associated with signi®cant inhibition of local IL-1 bioactivity 1.5 (96%), 3 (84%) and 5 h (72%), and in bioactive IL-6 in pouch lavage¯uid 1.5 (45%) and 5 h (35%), after LPS injection. The concentration of bioactive IL-6 in the plasma was signi®cantly reduced (39%) at 3 h, when temperature was approaching the maximal value. 5 Both systemic (i.p.) and central (i.c.v.) administration of IL-1ra signi®cantly attentuated LPS fever (P50.05). However, it had no eect on either local concentrations of bioactive IL-1 or IL-6, or circulating IL-6, at any of the sample points. 6 These data suggest that IL-1 is released locally, at the site of tissue in¯ammation and that it is an important mediator of the febrile response to local in¯ammation. The results also indicate that IL-1 produced locally may contribute to the production of IL-6 which is released into the circulation, and that IL-1 has important actions in the generation of fever at other sites, including the brain.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (31)

  1. BANKS, W.A., ORTIZ, L., PLOTKIN, S.R. & KASTIN, A.J. (1991). Human interleukin (IL)-1a, murine IL-1a and murine IL-1b are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther., 259, 988 ± 996.
  2. BANKS, W.A., KASTIN, A.J. & GUTIERREZ, E.G. (1994). Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett., 179, 53 ± 56.
  3. BLATTEIS, C.M. (1992). Role of the OVLT in the febrile response to circulating pyrogens. In Progress in Brain Research. Vol 92, ed. Ermisch, A., R., Landgraf & H.-J., RuÈ hle. pp. 409 ± 412. Amsterdam: Elsevier Science Publishers B.V.
  4. BLUTHE Â , R.M., DANTZER, R. & KELLY, K.W. (1992). Eects of interleukin-1 receptor antagonist on the behavioural eects of lipopolysaccharide in the rat. Brain Res., 573, 318 ± 320.
  5. BLUTHE Â , R.M., WALTER, V., PARNET, P., LAYE Â , S., LESTAGE, J., VERRIER, D., POOLE, S., STENNING, B.E., KELLY, K.W. & DANTZER, R. (1994). Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C.R. Acad. Sci. III (France), 317, 499 ± 503.
  6. BRISTOW, A.F., MOSLEY, K. & POOLE, S. (1991). Interluekin-1b production in vivo and in vitro in rats and mice measured using speci®c radioimmunometric assay. J. Mol. Endocrinol., 7, 1 ± 7.
  7. CANNON, J.G., TOMPKINS, R.G., GELFAND, R.A., MICHIE, H.R., STANFORD, G.G., VAN DER MEER, J.W.M., ENDRES, S., LONNE- MAN, G., CORSETTI, J., CHERNOW, B., WILMORE, D.W., WOLFF, S.M., BURKE, J.F. & DINARELLO, C.A. (1990). Circulating interleukin-1 and tumour necrosis factor in septic shock and endotoxin fever. J. Infect. Dis., 161, 79 ± 84.
  8. COOPER, A.L., KIRKMAN, E., LITTLE, R.A., HOPKINS, S.J. & ROTHWELL, N.J. (1991). Mechanisms involved in the fever and hypermetabolism induced by turpentine injection in the rat. Proc. Nutr. Soc., 50, 149A.
  9. DE SIMONI, M.G., SIRONI, M., DE LUIGI, A., MANFRIDI, A., MANTOVANI, A. & GHEZZI, P. (1990). Intracerebroventricular injection of interleukin-1 induces high circulating levels of interleukin-6. J. Exp. Med., 171, 1773 ± 1778.
  10. DRIPPS, D.J., BRANDHUBER, B.J., THOMPSON, R.C. & ERSENBERG, S.P. (1991). Interleukin (IL)-1 receptor antagonist binds to the 80kD IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem., 266, 10331 ± 10336.
  11. EDWARDS, J.C.W., SEDGWICK, A.D. & WILLOUGHBY, D.A. (1981). The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system. J. Pathol., 134, 147 ± 156.
  12. ENGEL, A., KERN, W.V., MURDTER, G. & KERN, P. (1994). Kinetics and correlation with body temperature of circulating interleukin- 6, interleukin-8, tumour necrosis factora and interleukin-1b in patients with fever and neutropenia. Infection, 22, 160 ± 164.
  13. GUTIERREZ, E.G., BANKS, W.A. & KASTIN, A.J. (1994). Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J. Neuroimmunol., 55, 153 ± 160.
  14. HOPKINS, S.J. & HUMPHREYS, M. (1989). Simple, sensitive and speci®c bioassay of interleukin-1. J. Immunol. Meth., 120, 271 ± 276. KLIR, J.J., MCCLELLAN, J.L. & KLUGER, M.J. (1994). Interleukin-1b causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am. J. Physiol., 266, R1845 ± 1848.
  15. KLIR, J.J., ROTH, J., SZELENYI, Z., MCCLELLAN, J.L. & KLUGER, M.J. (1993). Role of hypothalamic interleukin-6 and tumor necrosis factor-a in LPS fever in the rat. Am. J. Physiol. 265, R512 ± 517.
  16. KLUGER, M.J. (1991). Fever; Role of pyrogens and cryogens. Physiol. Rev., 71, 93 ± 127.
  17. LAYE Â , S., PARNET, P., GOUJON, E. & DANTZER, R. (1994). Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary in mice. Mol. Brain Res., 27, 157 ± 162.
  18. LAYE Â , S., BLUTHE Â , R.M., KENT, S., COMBE, C., MEDINA, C., PARNET, P., KELLY, K. & DANTZER, R. (1995). Subdiaphrag- matic vagotomy blocks induction of IL-1b mRNA in mice brain in response to peripheral LPS. Am. J. Physiol., 268, R1327 ± 1331.
  19. LEMAY, D.R., LEMAY, L.G., KLUGER, M.J. & D'ALECY, L.G. (1990a). Plasma pro®les of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am. J. Physiol., 259, R126 ± R132.
  20. LEMAY, L.G., OTTERNESS, I.G., VANDER, A.J. & KLUGER, M.J. (1990b). In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by IL-1b. Cytokine, 2, 199 ± 204.
  21. LEMAY, L.G., VANDER, A.J. & KLUGER, M.J. (1990c). Role of interleukin-6 in fever in rats. Am. J. Physiol., 258, R798 ± R803.
  22. LONG, N.C., OTTERNESS, I.G., KUNKEL, S.L., VANDER, A.J. & KLUGER, M.J. (1990). The roles of IL-1b and tumour necrosis factor in lipopolysaccharide-fever in the rat. Am. J. Physiol., 259, R724 ± R728.
  23. LUHESHI, G.N., MILLER, A.J., BROUWER, S., DASCOMBE, M.J., ROTHWELL, N.J. & HOPKINS, S.J. (1996). Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol., 270, E91 ± 95.
  24. MCINTYRE, K.W., STEPAN, D.J., KOLINSKY, K.D., BENJAMIN, W.R., PLOCINSKI, J.M., KAFFKA, K.L., CAMPEN, C.A., CHIZZONITE, R.A. & KILIAN, P.L. (1991). Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute in¯ammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J. Exp. Med., 173, 931 ± 939.
  25. MILLER, A.J., LUHESHI, G.N., ROTHWELL, N.J. & HOPKINS, S.J. (1996). Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Am. J. Physiol., (in press).
  26. NIJSTEN, M.W.N., DEGROOT, E.R., TEN DUIS, H.R., KLASEN, H.J., HACK, C.E. & AARDEN, L.A. (1987). Serum levels of interleukin-6 and acute phase responses. Lancet, 2, 921.
  27. OHLSSON, K., BJORK, P., BERGENGELDT, M., HAGEMAN, R. & THOMPSON, R.C. (1990). Interleukin-1 receptor antagonist reduces mortality from endotoxic shock. Nature, 348, 550 ± 552.
  28. OPP, M.R. & KRUEGER, J.M. (1991). Interleukin-1 receptor antagonist blocks interleukin-1 induced sleep and fever. Am. J. Physiol., 260, R453 ± 457.
  29. ROTHWELL, N.J., BUSBRIDGE, N.J., HUMPHRAY, H. & HISSEY, P. (1989). Central actions of interleukin-1b on fever and thermo- genesis (Abstract). Cytokine, 1, 153.
  30. SIRONI, M., BREVARIO, F., PROSENPIO, P., BIONDI, A., VECCHI, A., VAN DAMME, J., DEJANA, E.M. & MANTOVANI, A. (1989). IL-1 stimulates IL-6 production in endothelial cells. J. Immunol., 142, 549 ± 553.
  31. SMITH, B.K. & KLUGER, M.J. (1992). Human IL-1 receptor antagonist partially suppresses LPS fever but not plasma levels of IL-6 in Fischer rats. Am. J. Physiol., 263, R653 ± R655.